If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
5,050.00    25.00 (0.50%)
Bid:
5,070.00
Ask:
5,075.00
Spread: 5.00 (0.099%)
Market Cap: £18.41b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Transaction in Own Shares

25 Mar 2024 17:10

RNS Number : 2197I
Coca-Cola HBC AG
25 March 2024
 

FOR IMMEDIATE RELEASE

 

Coca-Cola HBC AG

 

Transactions in own shares

 

Zug, Switzerland - 25 March 2024 - Coca-Cola HBC AG ("Company") announces that it purchased the following number of its ordinary shares of 6.70 CHF each ("ordinary shares") on the London Stock Exchange, BATS Chi-X Europe and Aquis Stock Exchange Limited, through UBS AG London Branch ("UBS") as part of its share purchase programme announced on Monday 20 November 2023:

Date of transaction

25 March 2024

Number of shares repurchased:

55,282

Lowest price paid per share

£24.8000

Highest price paid per share

£25.0000

Volume weighted average price paid per share (GBP):

£24.9343

Broker

UBS

The purchased ordinary shares will be held in treasury until they are either used to meet the needs of the Company's employee incentive schemes or, by affirmative resolution of the Company's shareholders, cancelled.

As at 25 March 2024, the Company's issued share capital consisted of 373,136,556 ordinary shares, of which 4,661,369 ordinary shares are held by Coca-Cola HBC AG (including the purchased shares) and 3,430,135 ordinary shares are held by its subsidiary, Coca-Cola HBC Services MEPE, in treasury. Therefore, the total number of voting rights in the Company is 365,045,052 which may be used by shareholders as the denominator for calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Since announcing the share purchase programme on Monday 20 November 2023, the Company has purchased 3,668,619 of its ordinary shares.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) and Regulation (EU) No 596/2014 as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019, the schedule below provides detailed information about the transactions made by UBS on behalf of the Company as part of the share purchase programme.

http://www.rns-pdf.londonstockexchange.com/rns/2197I_1-2024-3-25.pdf

Schedule of purchases - Aggregated transactions

 

``

Trading venue

Volume weighted average price

Aggregated volume

 

London Stock Exchange

2,493.6593

24,860

BATS

2,492.5320

6,402

Chi-X

2,493.1768

18,408

Aquis

2,494.2206

5,612

 

 

Enquiries 

Coca-Cola HBC Group 

Investor and Analysts: 

John Dawson? 

Head of Investor Relations 

Tel: +44 7522 619509 

?john.dawson@cchellenic.com 

Jemima Benstead 

Investor Relations Manager 

Tel: +44 7740 535130 

jemima.benstead@cchellenic.com 

Sarah Hebert-Lilley

Investor Relations Manager 

Tel: +36 30 645 8678

Sarah.Hebert-Lilley@cchellenic.com

Individual Shareholders: 

Maria Livaniou 

Shareowner Services Manager 

 

 

 

Tel: +30 697 444 3270 

maria.livaniou@cchellenic.com 

 

Media: 

Sonia Bastian 

Head of Communications 

Tel: +41 7946 88054 

sonia.bastian@cchellenic.com 

Claire Evans

Group Senior Communications Manager - Corporate

 

Tel:?+44 7597 562 978 

claire.evans@cchellenic.com

 

 About Coca-Cola HBC

 

Coca-Cola HBC is a growth-focused consumer packaged goods business and strategic bottling partner of The Coca-Cola Company. We open up moments that refresh us all by creating value for our stakeholders and supporting the socio-economic development of the communities in which we operate. With a vision to be the leading 24/7 beverage partner, we offer drinks for all occasions around the clock and work together with our customers to serve 740 million consumers across a broad geographic footprint of 29 countries. Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, with consumer-leading beverage brands in the sparkling, adult sparkling, juice, water, sport, energy, ready-to-drink tea, coffee, and premium spirits categories. These include Coca-Cola, Coca-Cola Zero Sugar, Fanta, Sprite, Schweppes, Kinley, Costa Coffee, Caffè Vergnano, Valser, FuzeTea, Powerade, Cappy, Monster Energy, Finlandia Vodka, The Macallan, Jack Daniel's and Grey Goose. We foster an open and inclusive work environment amongst our 33,000 employees and believe that building a more positive environmental impact is integral to our future growth. We rank among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG, FTSE4Good and ISS ESG.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and is listed on the Athens Exchange (ATHEX: EEE). For more information, please visit https://www.coca-colahellenic.com.

 

Important notice relating to UBS

UBS AG London Branch ("UBS") is authorised and regulated by the Financial Market Supervisory Authority in Switzerland. It is authorised by the PRA and subject to regulation by the FCA and limited regulation by the PRA in the United Kingdom. UBS is acting exclusively for CCH and no one else in connection with the possible offer and the contents of this announcement. In connection with such matters, UBS will not regard any other person as its client, nor will it be responsible to any other person for providing the protections afforded to its clients or for providing advice in relation to the process, contents of this announcement or any other matter referred to herein.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSUVRBRSWUOUAR
Date   Source Headline
8th Oct 20241:06 pmRNSCCH holds webinar on Data, Insights and Analytics
4th Oct 20248:40 amRNSNotice of Results
1st Oct 20249:42 amRNSTotal Voting Rights
27th Sep 20245:17 pmRNSTransaction in Own Shares
26th Sep 20245:08 pmRNSTransaction in Own Shares
25th Sep 20245:06 pmRNSTransaction in Own Shares
23rd Sep 20245:05 pmRNSTransaction in Own Shares
20th Sep 20245:21 pmRNSTransaction in Own Shares
19th Sep 20245:04 pmRNSTransaction in Own Shares
19th Sep 20242:43 pmRNSDirector/PDMR Shareholding
18th Sep 20245:13 pmRNSTransaction in Own Shares
18th Sep 20242:40 pmRNSDirector/PDMR Shareholding
18th Sep 20247:15 amRNSTransaction in Own Shares
17th Sep 20248:01 amRNSReplacement - Composition of the Board Committees
17th Sep 20247:15 amRNSTransaction in Own Shares
16th Sep 20245:05 pmRNSComposition of the Committees of the Board
16th Sep 20244:59 pmRNSResult of Extraordinary General Meeting
11th Sep 20246:11 pmRNSTransaction in Own Shares
4th Sep 20249:37 amRNSDirector/PDMR Shareholding
4th Sep 20249:30 amRNSReplacement - Transaction in Own Shares
3rd Sep 20245:42 pmRNSTransaction in Own Shares
3rd Sep 202412:41 pmRNSDirector/PDMR Shareholding
2nd Sep 202412:20 pmRNSAthens Exchange trading date of ordinary shares
2nd Sep 202410:01 amRNSDirector/PDMR Shareholding
2nd Sep 20249:53 amRNSDirector/PDMR Shareholding
2nd Sep 20248:44 amRNSTotal Voting Rights
30th Aug 20249:21 amRNSParticipating in Barclays Conference
29th Aug 20245:01 pmRNSTransaction in Own Shares
28th Aug 20245:09 pmRNSTransaction in Own Shares
27th Aug 20245:06 pmRNSTransaction in Own Shares
23rd Aug 20245:24 pmRNSTransaction in Own Shares
23rd Aug 20248:32 amRNSNotice of EGM
22nd Aug 20245:18 pmRNSTransaction in Own Shares
21st Aug 20245:08 pmRNSTransaction in Own Shares
21st Aug 20247:10 amRNSTransaction in Own Shares
19th Aug 20245:22 pmRNSTransaction in Own Shares
19th Aug 20241:06 pmRNSDirector/PDMR Shareholding
19th Aug 20247:53 amRNSTransaction in Own Shares
16th Aug 20247:15 amRNSTransaction in Own Shares
14th Aug 20245:16 pmRNSTransaction in Own Shares
13th Aug 20245:11 pmRNSTransaction in Own Shares
12th Aug 20245:28 pmRNSTransaction in Own Shares
9th Aug 20245:22 pmRNSTransaction in Own Shares
9th Aug 202410:14 amRNSresignation of director Anna Diamantopoulou
8th Aug 20245:12 pmRNSTransaction in Own Shares
7th Aug 20247:00 amRNSStrong growth and share gains
1st Aug 202410:53 amRNSTransfer of treasuryshares and total voting rights
18th Jul 20242:33 pmRNSDirector/PDMR Shareholding
15th Jul 202412:39 pmRNSNotice of Results
1st Jul 20244:59 pmRNSTransfer of treasuryshares and total voting rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.